Table III.
Active hip joint movements made voluntarily by patients before treatment andafter 4 months of treatment with standardized rose-hip powder (SRHP) and placebo.
| Type of Movement | Baseline, deg∗ | Restriction of Movement, deg | At 4 Months of Therapy, deg∗ | Improvement, % |
|---|---|---|---|---|
| Flexion | ||||
| SRHP | 105.60 (13.10) | 19.4 | 109.79 (14.71)†‡ | 22.3 |
| Placebo | 97.63 (15.49) | 27.3 | 102.06 (15.11)‡ | 15.2 |
| External rotation | ||||
| SRHP | 20.00 (9.79) | 25.0 | 21.87 (9.19)§ | 10.5 |
| Placebo | 13.06 (10.17) | 31.9 | 15.94 (9.70)‡ | 7.9 |
| Internal rotation | ||||
| SRHP | 21.20 (12.61) | 23.8 | 24.58 (14.52)∥ | 14.8 |
| Placebo | 21.39 (10.68) | 23.6 | 25.94 (11.58)¶ | 16.4 |
∗
Values are expressed as mean (SD).
†
P=0.002 versus pretreatment.
‡
P=0.026 versus placebo.
§
P=0.023 versus pretreatment.
∥
P=0.010 versus pretreatment.
¶
P=0.023 versus pretreatment.